Sign in →

Test Code ACL Panel Anti-Cardiolipin Panel

Useful For

To aid in the diagnosis of thrombotic disorders related to primary & secondary anti-phospholipid syndrome (APS)

Patient Preparation

No special patient preparation required

Collection Method

Venous collection

Minimum Volume

2 mL

Container

Gold Top Serum Separator

Preferred Specimen

Serum

Acceptable Specimens

Serum:

  • Gold Top SST

  • Red Top

Plasma:
  • Light Geen Top (lithium heparin)

Reference or Target Ranges

ACL IgA:
<20
ACL IgG:
<20
ACL IgM:
<20

Reportable Units

RLU

Critical Value

Not defined for this assay

Reasons for Rejection

Hemolysis Threshold
N/A
Icterus Threshold
N/A
Lipemia Threshold
N/A
Other
QNS, contaminated, improperly labeled, improper specimen type

Specimen Stability

Ambient
N/A
Refrigerated (4°C to 8°C)
48 Hours
Frozen(-70°C to 0°C)
Indefinitely

Performance Information

Days and Time Performed
Tuesday, Thursday, and Friday 7 AM – 4 PM
Expected Turn Around Time
Within 7 days of arrival in lab
Stat Availability
No
Performing Bench
ANA
Methodology/Method Description
Bioflash – Chemilluminescence

Additional Information/Important Notes

Anticardiolipin antibodies (ACA) may be associated with thrombosis and pregnancy morbidity and loss and may be a serologic part of the antiphospholipid syndrome. ACA can transiently increase in infections. The diagnosis of antiphospholipid syndrome (APS) requires an appropriate clinical picture and the presence of persistently positive antiphospholipid antibodies (anticardiolipin, lupus anticoagulant, or anti-beta2 glycoprotein-I). ACA of medium or high titer consistently positive when checked 12 weeks apart meets one of the criteria for APL syndrome. The significance of isolated elevated ACA IgA is uncertain.

CPT Codes

86147 x3

Panel Components

  • ACL IgA
  • ACL IgG
  • ACL IgM